z-logo
open-access-imgOpen Access
Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin‑resistant human epidermal growth factor receptor 2‑positive breast cancer
Author(s) -
Junjun Liu,
Hanzhi Ding,
Quan Hong,
Jing Han
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12927
Subject(s) - niclosamide , cancer research , breast cancer , cancer , cancer stem cell , epithelial–mesenchymal transition , cisplatin , biology , cell growth , metastasis , medicine , chemotherapy , ecology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here